HTLV-1-Associated Myelopathy (HAM)
1 clinical trials · Condition
◉ Watch HTLV-1-Associated Myelopathy (HAM)
| Record | Firm | Date |
|---|---|---|
| A Clinical Pharmacological Study of MT-3921 in Subjects With HTLV-1 Associated Myelopathy (HAM) (NCT05240612) | Tanabe Pharma Corporation | 2022-05-02 |
Track HTLV-1-Associated Myelopathy (HAM) automatically
Every clearance here is in the API, with alerts when new ones post.